IMP: Reporting dossiers on the change of the maximum foreign ownership ratio

Reporting dossiers on the change of the maximum foreign ownership ratio of Imexpharm Corporation as follows: 

HOSE

>   PGD: Approval on transaction with related party (05/06/2025)

>   HTG: Approval of the termination of business location (05/06/2025)

>   C47: Signing construction package (05/06/2025)

>   TCB: Amendment of Establishment and Operation License (05/06/2025)

>   SHI: BOD resolution on selecting the audit firm (05/06/2025)

>   NT2: BOD resolutions dated June 04, 2025 (05/06/2025)

>   NHA: Change of outstanding voting shares (05/06/2025)

>   KSB: Reporting dossiers on the maximum foreign ownership ratio (05/06/2025)

>   BCM: Approval of the record date to collect shareholders' written opinions (05/06/2025)

>   APG: Adjusting reviewed financial safety ratio report as of 30 June 2024 (05/06/2025)